1. Home
  2. INM

INM

InMed Pharmaceuticals Inc.

Logo InMed Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Founded: N/A Country:
Canada
Canada
Employees: N/A City: VANCOUVER
Market Cap: 1.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 308.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.27 EPS Growth: N/A
52 Week Low/High: $0.29 - $2.08 Next Earning Date: 05-13-2024
Revenue: $5,487,052 Revenue Growth: 239.77%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: